These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 20860672

  • 1. HIV/AIDS: vaccines and alternate strategies for treatment and prevention.
    Voronin Y, Phogat S.
    Ann N Y Acad Sci; 2010 Sep; 1205 Suppl 1():E1-9. PubMed ID: 20860672
    [Abstract] [Full Text] [Related]

  • 2. The 2017 Keystone Symposium on HIV Vaccines.
    Cottrell CA, Ward AB.
    Hum Vaccin Immunother; 2017 Oct 03; 13(10):2348-2351. PubMed ID: 28786733
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
    Liu Q, Li Y, Luo Z, Yang G, Liu Y, Liu Y, Sun M, Dai J, Li Q, Qin C, Shao Y.
    AIDS; 2015 Mar 27; 29(6):649-58. PubMed ID: 25849828
    [Abstract] [Full Text] [Related]

  • 5. HIV Vaccination: A Roadmap among Advancements and Concerns.
    Trovato M, D'Apice L, Prisco A, De Berardinis P.
    Int J Mol Sci; 2018 Apr 19; 19(4):. PubMed ID: 29671786
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. RV144: old vs. new.
    Weiner DB.
    Hum Vaccin; 2010 Feb 19; 6(2):159-61. PubMed ID: 20431335
    [No Abstract] [Full Text] [Related]

  • 8. A shot at AIDS.
    Koff WC.
    Curr Opin Biotechnol; 2016 Dec 19; 42():147-151. PubMed ID: 27153215
    [Abstract] [Full Text] [Related]

  • 9. Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
    Le Grand R, Dereuddre-Bosquet N, Dispinseri S, Gosse L, Desjardins D, Shen X, Tolazzi M, Ochsenbauer C, Saidi H, Tomaras G, Prague M, Barnett SW, Thiebaut R, Cope A, Scarlatti G, Shattock RJ.
    J Virol; 2016 Jun 01; 90(11):5315-5328. PubMed ID: 27009957
    [Abstract] [Full Text] [Related]

  • 10. HIV neutralizing antibodies reignite interest in vaccine.
    Waltz E.
    Nat Biotechnol; 2012 Mar 07; 30(3):204-5. PubMed ID: 22398603
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Broadly neutralizing antibodies against HIV-1: templates for a vaccine.
    van Gils MJ, Sanders RW.
    Virology; 2013 Jan 05; 435(1):46-56. PubMed ID: 23217615
    [Abstract] [Full Text] [Related]

  • 13. HIV vaccine development.
    Watkins DI.
    Top HIV Med; 2010 Jan 05; 18(2):35-6. PubMed ID: 20516522
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immune Correlate-Guided HIV Vaccine Design.
    Alter G, Barouch D.
    Cell Host Microbe; 2018 Jul 11; 24(1):25-33. PubMed ID: 30001521
    [Abstract] [Full Text] [Related]

  • 18. Germinal Center Lymphocyte Ratios and Successful HIV Vaccines.
    Gonzalez-Figueroa P, Roco JA, Vinuesa CG.
    Trends Mol Med; 2017 Feb 11; 23(2):95-97. PubMed ID: 28089302
    [Abstract] [Full Text] [Related]

  • 19. Development of an AIDS vaccine: a daunting epidemiological challenge.
    Nathanson N, Mathieson BJ.
    Eur J Epidemiol; 2005 Feb 11; 20(2):123-6. PubMed ID: 15792276
    [No Abstract] [Full Text] [Related]

  • 20. AIDS vaccine shows promise after years of frustration.
    Cohen J.
    Science; 2001 Mar 02; 291(5509):1686-8. PubMed ID: 11263450
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.